Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
3,00,004.00
3,01,965.00
2,79,037.00
2,66,257.00
2,49,605.00
2,41,555.00
2,34,026.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,00,004.00
3,01,965.00
2,79,037.00
2,66,257.00
2,49,605.00
2,41,555.00
2,34,026.00
Raw Material Cost
1,36,795.00
1,38,089.00
1,22,468.00
1,19,405.00
1,08,871.00
1,06,852.00
99,861.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
57,319.00
63,870.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1,083.00
831.00
486.00
250.00
172.00
750.00
7.00
Selling and Distribution Expenses
83,511.00
87,270.00
96,257.00
84,499.00
79,554.00
71,898.00
69,795.00
Other Expenses
-3,493.50
-3,999.80
2,781.10
2,612.70
2,394.00
2,193.00
2,312.10
Total Expenditure (Excl Depreciation)
2,43,773.00
2,50,062.00
2,47,022.00
2,30,281.00
2,12,537.00
2,01,430.00
1,92,784.00
Operating Profit (PBDIT) excl Other Income
56231
51903
32015
35976
37068
40125
41242
Other Income
3,159.00
2,094.00
107.00
684.00
15,805.00
-46.00
3,338.00
Operating Profit (PBDIT)
77,338.00
72,175.00
49,371.00
53,715.00
70,795.00
56,652.00
55,549.00
Interest
1,083.00
831.00
486.00
250.00
172.00
750.00
7.00
Exceptional Items
-10,140.00
-15,718.00
-35,073.00
809.00
-40,788.00
-7,237.00
-1,458.00
Gross Profit (PBDT)
1,63,209.00
1,63,876.00
1,56,569.00
1,46,852.00
1,40,734.00
1,34,703.00
1,34,165.00
Depreciation
17,948.00
18,178.00
17,249.00
17,055.00
17,922.00
16,573.00
10,969.00
Profit Before Tax
48,166.00
37,449.00
-3,437.00
37,220.00
12,046.00
32,091.00
43,117.00
Tax
11,628.00
3,171.00
9,184.00
8,427.00
2,562.00
10,377.00
11,174.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
36,247.00
26,635.00
-14,955.00
27,224.00
9,315.00
23,616.00
31,953.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
36,247.00
26,635.00
-14,955.00
27,224.00
9,315.00
23,616.00
31,953.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-403.00
60.00
-35.00
-29.00
-185.00
-1,904.00
-11.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
35,844.00
26,695.00
-14,990.00
27,195.00
9,130.00
21,712.00
31,942.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,86,242.00
3,06,054.00
2,93,979.00
3,37,488.00
3,10,181.00
3,02,865.00
2,90,900.00
Earnings per share (EPS)
103.68
72.37
-38.6
67.97
23.25
59.01
78.43
Diluted Earnings per share
103.68
72.37
-38.6
67.97
23.25
59.01
78.43
Operating Profit Margin (Excl OI)
18.74%
17.19%
11.47%
13.51%
14.85%
16.61%
17.62%
Gross Profit Margin
22.04%
18.42%
4.95%
20.38%
12.01%
20.15%
23.11%
PAT Margin
12.08%
8.82%
-5.36%
10.22%
3.73%
9.78%
13.65%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -0.65% vs 8.22% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 34.27% vs 278.09% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 5.85% vs 42.26% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 30.32% vs 70.99% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Santen Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(JPY)
Change(%)
Net Sales
3,00,004.00
1,65,600.00
1,34,404.00
81.16%
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,00,004.00
1,65,600.00
1,34,404.00
81.16%
Raw Material Cost
1,36,795.00
82,837.00
53,958.00
65.14%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
57,319.00
0.00
57,319.00
Power Cost
0
0
0.00
Manufacturing Expenses
1,083.00
28.00
1,055.00
3,767.86%
Selling and Distribution Expenses
83,511.00
48,040.00
35,471.00
73.84%
Other Expenses
-3,493.50
908.10
-4,401.60
-484.70%
Total Expenditure (Excl Depreciation)
2,43,773.00
1,39,986.00
1,03,787.00
74.14%
Operating Profit (PBDIT) excl Other Income
56,231.00
25,614.00
30,617.00
119.53%
Other Income
3,159.00
2,764.00
395.00
14.29%
Operating Profit (PBDIT)
77,338.00
35,647.00
41,691.00
116.96%
Interest
1,083.00
28.00
1,055.00
3,767.86%
Exceptional Items
-10,140.00
-13,687.00
3,547.00
25.92%
Gross Profit (PBDT)
1,63,209.00
82,763.00
80,446.00
97.20%
Depreciation
17,948.00
8,022.00
9,926.00
123.73%
Profit Before Tax
48,166.00
13,914.00
34,252.00
246.17%
Tax
11,628.00
3,842.00
7,786.00
202.65%
Provisions and contingencies
0
0
0.00
Profit After Tax
36,247.00
10,067.00
26,180.00
260.06%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
36,247.00
10,067.00
26,180.00
260.06%
Share in Profit of Associates
0
0
0.00
Minority Interest
-403.00
4.00
-407.00
-10,175.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
35,844.00
10,071.00
25,773.00
255.91%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
2,86,242.00
2,13,467.00
72,775.00
34.09%
Earnings per share (EPS)
103.68
135.42
-31.74
-23.44%
Diluted Earnings per share
103.68
135.42
-31.74
-23.44%
Operating Profit Margin (Excl OI)
18.74%
15.01%
0.00
3.73%
Gross Profit Margin
22.04%
13.25%
0.00
8.79%
PAT Margin
12.08%
6.08%
0.00
6.00%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 30,000.40 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -0.65% vs 8.22% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 3,584.40 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 34.27% vs 278.09% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7,417.90 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 5.85% vs 42.26% in Mar 2024
Annual - Interest
Interest 108.30 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 30.32% vs 70.99% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.74%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
